
Neuropsychiatry Center of Therapeutic Innovation
125, Chemin de Ronde
78290 Croissy-sur-Seine
France
Project Leader

Project Staff


Institute presentation
We are an international and independent pharmaceutical company governed by a non-profit foundation, with headquarters in Suresnes, France. Operating in 148 countries, we have 21,000 collaborators employed worldwide and a turnover of 4 billion euros in 2016. Entirely independent, we are able to reinvest 25% of our total revenue (excluding generics) into Research and Development, and all profits are used for further development. Corporate growth at Servier is driven by our continuous pursuit of innovation in five areas of excellence: cardiovascular and immune-inflammatory diseases, neuropsychiatric disorders, cancer and diabetes. We are a leading force in cardiology—number 2 in Europe, number 8 worldwide—and oncology has become a top priority in recent years; we also manufacture high-quality generic drugs.